Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Novo Nordisk Says Our Proposal Offers Compelling Value To Metsera Stockholders That Far Exceeds Pfizer's Proposed Transaction; We Closely Adhered To All Of The Restrictions Under The Pfizer Merger Agreement And Are Confident That The Facts And The Law Are On Our Side

Author: Benzinga Newsdesk | November 03, 2025 11:16am

- Reuters

Posted In: MTSR NVO PFE